Minimally Invasive Biopsy Techniques Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product Offered (Tests, Kits & Consumables, Instruments), By Technique (Liquid Biopsy, Optical Biopsy, Brush Biopsy, Pigmented Lesion Assays, Others {Breath Biopsy etc.}), By Circulating Biomarker (Circulating Tumor Cells (CTCs), Cell Free DNA (cfDNA), Circulating Tumor DNA (ctDNA), Extracellular Vesicles, Others {miRNA, CTECs, circRNA etc.}), By Application (Clinical and Therapeutic), By End User (Hospitals & Clinics, Ambulatory Care Center, Academic & Research Institutions), By Region, By Competition, 2020-2030F
The Global Minimally Invasive Biopsy Techniques Market, valued at USD 13.75 Billion in 2024, is projected to experience a CAGR of 10.30% to reach USD 24.76 Billion by 2030. Minimally invasive biopsy techniques involve diagnostic procedures designed to obtain tissue or fluid samples with reduced physical trauma, shorter recovery times, and decreased complication risks compared to conventional surgical biopsies. Key drivers propelling this market's growth include the rising global prevalence of cancer and other conditions necessitating definitive tissue diagnosis, an increasing patient inclination towards less invasive medical interventions, and continuous technological advancements in imaging guidance and device precision. These innovations enhance the accuracy and efficiency of sample collection, supporting broader clinical
Key Market Drivers
The increasing global burden of cancer and chronic diseases stands as a primary catalyst for the expansion of the minimally invasive biopsy techniques market. As diagnostic needs escalate for a growing patient population, the imperative for accurate and timely tissue sampling intensifies. These techniques offer a less intrusive yet highly effective method for obtaining critical diagnostic information, directly responding to the rising disease prevalence. According to the World Health Organization (WHO), on February 1, 2024, in 'Global cancer burden growing, amidst mounting need for services,' there were an estimated 20 million new cancer cases globally in 2022, underscoring the vast and continuous demand for robust diagnostic interventions. This widespread incidence drives healthcare systems to prioritize efficient and patient-friendly diagnostic pathways.
Key Market Challenges
The inherent technical complexity and demanding learning curve associated with specialized minimally invasive biopsy procedures represent a significant challenge to the growth of the Global Minimally Invasive Biopsy Techniques Market. These procedures require extensive training and substantial expertise from healthcare professionals to ensure optimal diagnostic yield and patient safety. This stringent requirement limits the number of practitioners qualified to perform these advanced techniques, directly impeding broader clinical adoption.
Key Market Trends
Liquid biopsy dominance and expansion represents a pivotal trend reshaping cancer diagnostics by offering minimally invasive methods for disease detection and surveillance. These blood-based tests analyze circulating tumor DNA and other biomarkers, providing a less intrusive alternative to conventional tissue biopsies, especially beneficial for inaccessible tumors or for continuous monitoring of treatment efficacy. The Association for Molecular Pathology and the College of American Pathologists collectively published 13 best practice recommendations for validating and reporting clinical circulating tumor DNA assays, indicating a growing formalization and clinical acceptance of these techniques in October 2023. This advancement facilitates earlier detection of recurrence and precise assessment of therapeutic response.
Key Market Players
In this report, the Global Minimally Invasive Biopsy Techniques Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Company Profiles: Detailed analysis of the major companies presents in the Global Minimally Invasive Biopsy Techniques Market.
Available Customizations:
Global Minimally Invasive Biopsy Techniques Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
Key Market Drivers
The increasing global burden of cancer and chronic diseases stands as a primary catalyst for the expansion of the minimally invasive biopsy techniques market. As diagnostic needs escalate for a growing patient population, the imperative for accurate and timely tissue sampling intensifies. These techniques offer a less intrusive yet highly effective method for obtaining critical diagnostic information, directly responding to the rising disease prevalence. According to the World Health Organization (WHO), on February 1, 2024, in 'Global cancer burden growing, amidst mounting need for services,' there were an estimated 20 million new cancer cases globally in 2022, underscoring the vast and continuous demand for robust diagnostic interventions. This widespread incidence drives healthcare systems to prioritize efficient and patient-friendly diagnostic pathways.
Key Market Challenges
The inherent technical complexity and demanding learning curve associated with specialized minimally invasive biopsy procedures represent a significant challenge to the growth of the Global Minimally Invasive Biopsy Techniques Market. These procedures require extensive training and substantial expertise from healthcare professionals to ensure optimal diagnostic yield and patient safety. This stringent requirement limits the number of practitioners qualified to perform these advanced techniques, directly impeding broader clinical adoption.
Key Market Trends
Liquid biopsy dominance and expansion represents a pivotal trend reshaping cancer diagnostics by offering minimally invasive methods for disease detection and surveillance. These blood-based tests analyze circulating tumor DNA and other biomarkers, providing a less intrusive alternative to conventional tissue biopsies, especially beneficial for inaccessible tumors or for continuous monitoring of treatment efficacy. The Association for Molecular Pathology and the College of American Pathologists collectively published 13 best practice recommendations for validating and reporting clinical circulating tumor DNA assays, indicating a growing formalization and clinical acceptance of these techniques in October 2023. This advancement facilitates earlier detection of recurrence and precise assessment of therapeutic response.
Key Market Players
- F. Hoffmann-La Roche AG
- Thermo Fisher Scientific, Inc.
- PerkinElmer Inc.
- QIAGEN NV
- Guardant Health, Inc.
- Veracyte, Inc.
- Myriad Genetics, Inc.
- Biocept, Inc.
- NeoGenomics Laboratories, Inc.
- Adaptive Biotechnologies Corporation
In this report, the Global Minimally Invasive Biopsy Techniques Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
- Minimally Invasive Biopsy Techniques Market, By Product Offered:
- Tests
- Kits & Consumables
- Instruments
- Minimally Invasive Biopsy Techniques Market, By Technique:
- Liquid Biopsy
- Optical Biopsy
- Brush Biopsy
- Pigmented Lesion Assays
- Others
- Minimally Invasive Biopsy Techniques Market, By Circulating Biomarker:
- Circulating Tumor Cells (CTCs)
- Cell Free DNA (cfDNA)
- Circulating Tumor DNA (ctDNA)
- Extracellular Vesicles
- Others
- Minimally Invasive Biopsy Techniques Market, By Application:
- Clinical
- Therapeutic
- Minimally Invasive Biopsy Techniques Market, By End User:
- Hospitals & Clinics
- Ambulatory Care Center
- Academic & Research Institutions
- Minimally Invasive Biopsy Techniques Market, By Region:
- North America
- United States
- Canada
- Mexico
- Europe
- France
- United Kingdom
- Italy
- Germany
- Spain
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- South America
- Brazil
- Argentina
- Colombia
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
Company Profiles: Detailed analysis of the major companies presents in the Global Minimally Invasive Biopsy Techniques Market.
Available Customizations:
Global Minimally Invasive Biopsy Techniques Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up to five).
1. PRODUCT OVERVIEW
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. RESEARCH METHODOLOGY
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. EXECUTIVE SUMMARY
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. VOICE OF CUSTOMER
5. GLOBAL MINIMALLY INVASIVE BIOPSY TECHNIQUES MARKET OUTLOOK
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Product Offered (Tests, Kits & Consumables, Instruments)
5.2.2. By Technique (Liquid Biopsy, Optical Biopsy, Brush Biopsy, Pigmented Lesion Assays, Others)
5.2.3. By Circulating Biomarker (Circulating Tumor Cells (CTCs), Cell Free DNA (cfDNA), Circulating Tumor DNA (ctDNA), Extracellular Vesicles, Others)
5.2.4. By Application (Clinical, Therapeutic)
5.2.5. By End User (Hospitals & Clinics, Ambulatory Care Center, Academic & Research Institutions)
5.2.6. By Region
5.2.7. By Company (2024)
5.3. Market Map
6. NORTH AMERICA MINIMALLY INVASIVE BIOPSY TECHNIQUES MARKET OUTLOOK
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Product Offered
6.2.2. By Technique
6.2.3. By Circulating Biomarker
6.2.4. By Application
6.2.5. By End User
6.2.6. By Country
6.3. North America: Country Analysis
6.3.1. United States Minimally Invasive Biopsy Techniques Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Product Offered
6.3.1.2.2. By Technique
6.3.1.2.3. By Circulating Biomarker
6.3.1.2.4. By Application
6.3.1.2.5. By End User
6.3.2. Canada Minimally Invasive Biopsy Techniques Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Product Offered
6.3.2.2.2. By Technique
6.3.2.2.3. By Circulating Biomarker
6.3.2.2.4. By Application
6.3.2.2.5. By End User
6.3.3. Mexico Minimally Invasive Biopsy Techniques Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Product Offered
6.3.3.2.2. By Technique
6.3.3.2.3. By Circulating Biomarker
6.3.3.2.4. By Application
6.3.3.2.5. By End User
7. EUROPE MINIMALLY INVASIVE BIOPSY TECHNIQUES MARKET OUTLOOK
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Product Offered
7.2.2. By Technique
7.2.3. By Circulating Biomarker
7.2.4. By Application
7.2.5. By End User
7.2.6. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Minimally Invasive Biopsy Techniques Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Product Offered
7.3.1.2.2. By Technique
7.3.1.2.3. By Circulating Biomarker
7.3.1.2.4. By Application
7.3.1.2.5. By End User
7.3.2. France Minimally Invasive Biopsy Techniques Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Product Offered
7.3.2.2.2. By Technique
7.3.2.2.3. By Circulating Biomarker
7.3.2.2.4. By Application
7.3.2.2.5. By End User
7.3.3. United Kingdom Minimally Invasive Biopsy Techniques Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Product Offered
7.3.3.2.2. By Technique
7.3.3.2.3. By Circulating Biomarker
7.3.3.2.4. By Application
7.3.3.2.5. By End User
7.3.4. Italy Minimally Invasive Biopsy Techniques Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Product Offered
7.3.4.2.2. By Technique
7.3.4.2.3. By Circulating Biomarker
7.3.4.2.4. By Application
7.3.4.2.5. By End User
7.3.5. Spain Minimally Invasive Biopsy Techniques Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Product Offered
7.3.5.2.2. By Technique
7.3.5.2.3. By Circulating Biomarker
7.3.5.2.4. By Application
7.3.5.2.5. By End User
8. ASIA PACIFIC MINIMALLY INVASIVE BIOPSY TECHNIQUES MARKET OUTLOOK
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Product Offered
8.2.2. By Technique
8.2.3. By Circulating Biomarker
8.2.4. By Application
8.2.5. By End User
8.2.6. By Country
8.3. Asia Pacific: Country Analysis
8.3.1. China Minimally Invasive Biopsy Techniques Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Product Offered
8.3.1.2.2. By Technique
8.3.1.2.3. By Circulating Biomarker
8.3.1.2.4. By Application
8.3.1.2.5. By End User
8.3.2. India Minimally Invasive Biopsy Techniques Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Product Offered
8.3.2.2.2. By Technique
8.3.2.2.3. By Circulating Biomarker
8.3.2.2.4. By Application
8.3.2.2.5. By End User
8.3.3. Japan Minimally Invasive Biopsy Techniques Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Product Offered
8.3.3.2.2. By Technique
8.3.3.2.3. By Circulating Biomarker
8.3.3.2.4. By Application
8.3.3.2.5. By End User
8.3.4. South Korea Minimally Invasive Biopsy Techniques Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Product Offered
8.3.4.2.2. By Technique
8.3.4.2.3. By Circulating Biomarker
8.3.4.2.4. By Application
8.3.4.2.5. By End User
8.3.5. Australia Minimally Invasive Biopsy Techniques Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Product Offered
8.3.5.2.2. By Technique
8.3.5.2.3. By Circulating Biomarker
8.3.5.2.4. By Application
8.3.5.2.5. By End User
9. MIDDLE EAST & AFRICA MINIMALLY INVASIVE BIOPSY TECHNIQUES MARKET OUTLOOK
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Product Offered
9.2.2. By Technique
9.2.3. By Circulating Biomarker
9.2.4. By Application
9.2.5. By End User
9.2.6. By Country
9.3. Middle East & Africa: Country Analysis
9.3.1. Saudi Arabia Minimally Invasive Biopsy Techniques Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Product Offered
9.3.1.2.2. By Technique
9.3.1.2.3. By Circulating Biomarker
9.3.1.2.4. By Application
9.3.1.2.5. By End User
9.3.2. UAE Minimally Invasive Biopsy Techniques Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Product Offered
9.3.2.2.2. By Technique
9.3.2.2.3. By Circulating Biomarker
9.3.2.2.4. By Application
9.3.2.2.5. By End User
9.3.3. South Africa Minimally Invasive Biopsy Techniques Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Product Offered
9.3.3.2.2. By Technique
9.3.3.2.3. By Circulating Biomarker
9.3.3.2.4. By Application
9.3.3.2.5. By End User
10. SOUTH AMERICA MINIMALLY INVASIVE BIOPSY TECHNIQUES MARKET OUTLOOK
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Product Offered
10.2.2. By Technique
10.2.3. By Circulating Biomarker
10.2.4. By Application
10.2.5. By End User
10.2.6. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Minimally Invasive Biopsy Techniques Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Product Offered
10.3.1.2.2. By Technique
10.3.1.2.3. By Circulating Biomarker
10.3.1.2.4. By Application
10.3.1.2.5. By End User
10.3.2. Colombia Minimally Invasive Biopsy Techniques Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Product Offered
10.3.2.2.2. By Technique
10.3.2.2.3. By Circulating Biomarker
10.3.2.2.4. By Application
10.3.2.2.5. By End User
10.3.3. Argentina Minimally Invasive Biopsy Techniques Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Product Offered
10.3.3.2.2. By Technique
10.3.3.2.3. By Circulating Biomarker
10.3.3.2.4. By Application
10.3.3.2.5. By End User
11. MARKET DYNAMICS
11.1. Drivers
11.2. Challenges
12. MARKET TRENDS & DEVELOPMENTS
12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments
13. GLOBAL MINIMALLY INVASIVE BIOPSY TECHNIQUES MARKET: SWOT ANALYSIS
14. PORTER'S FIVE FORCES ANALYSIS
14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products
15. COMPETITIVE LANDSCAPE
15.1. F. Hoffmann-La Roche AG
15.1.1. Business Overview
15.1.2. Products & Services
15.1.3. Recent Developments
15.1.4. Key Personnel
15.1.5. SWOT Analysis
15.2. Thermo Fisher Scientific, Inc.
15.3. PerkinElmer Inc.
15.4. QIAGEN NV
15.5. Guardant Health, Inc.
15.6. Veracyte, Inc.
15.7. Myriad Genetics, Inc.
15.8. Biocept, Inc.
15.9. NeoGenomics Laboratories, Inc.
15.10. Adaptive Biotechnologies Corporation
16. STRATEGIC RECOMMENDATIONS
17. ABOUT US & DISCLAIMER
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. RESEARCH METHODOLOGY
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. EXECUTIVE SUMMARY
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. VOICE OF CUSTOMER
5. GLOBAL MINIMALLY INVASIVE BIOPSY TECHNIQUES MARKET OUTLOOK
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Product Offered (Tests, Kits & Consumables, Instruments)
5.2.2. By Technique (Liquid Biopsy, Optical Biopsy, Brush Biopsy, Pigmented Lesion Assays, Others)
5.2.3. By Circulating Biomarker (Circulating Tumor Cells (CTCs), Cell Free DNA (cfDNA), Circulating Tumor DNA (ctDNA), Extracellular Vesicles, Others)
5.2.4. By Application (Clinical, Therapeutic)
5.2.5. By End User (Hospitals & Clinics, Ambulatory Care Center, Academic & Research Institutions)
5.2.6. By Region
5.2.7. By Company (2024)
5.3. Market Map
6. NORTH AMERICA MINIMALLY INVASIVE BIOPSY TECHNIQUES MARKET OUTLOOK
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Product Offered
6.2.2. By Technique
6.2.3. By Circulating Biomarker
6.2.4. By Application
6.2.5. By End User
6.2.6. By Country
6.3. North America: Country Analysis
6.3.1. United States Minimally Invasive Biopsy Techniques Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Product Offered
6.3.1.2.2. By Technique
6.3.1.2.3. By Circulating Biomarker
6.3.1.2.4. By Application
6.3.1.2.5. By End User
6.3.2. Canada Minimally Invasive Biopsy Techniques Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Product Offered
6.3.2.2.2. By Technique
6.3.2.2.3. By Circulating Biomarker
6.3.2.2.4. By Application
6.3.2.2.5. By End User
6.3.3. Mexico Minimally Invasive Biopsy Techniques Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Product Offered
6.3.3.2.2. By Technique
6.3.3.2.3. By Circulating Biomarker
6.3.3.2.4. By Application
6.3.3.2.5. By End User
7. EUROPE MINIMALLY INVASIVE BIOPSY TECHNIQUES MARKET OUTLOOK
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Product Offered
7.2.2. By Technique
7.2.3. By Circulating Biomarker
7.2.4. By Application
7.2.5. By End User
7.2.6. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Minimally Invasive Biopsy Techniques Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Product Offered
7.3.1.2.2. By Technique
7.3.1.2.3. By Circulating Biomarker
7.3.1.2.4. By Application
7.3.1.2.5. By End User
7.3.2. France Minimally Invasive Biopsy Techniques Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Product Offered
7.3.2.2.2. By Technique
7.3.2.2.3. By Circulating Biomarker
7.3.2.2.4. By Application
7.3.2.2.5. By End User
7.3.3. United Kingdom Minimally Invasive Biopsy Techniques Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Product Offered
7.3.3.2.2. By Technique
7.3.3.2.3. By Circulating Biomarker
7.3.3.2.4. By Application
7.3.3.2.5. By End User
7.3.4. Italy Minimally Invasive Biopsy Techniques Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Product Offered
7.3.4.2.2. By Technique
7.3.4.2.3. By Circulating Biomarker
7.3.4.2.4. By Application
7.3.4.2.5. By End User
7.3.5. Spain Minimally Invasive Biopsy Techniques Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Product Offered
7.3.5.2.2. By Technique
7.3.5.2.3. By Circulating Biomarker
7.3.5.2.4. By Application
7.3.5.2.5. By End User
8. ASIA PACIFIC MINIMALLY INVASIVE BIOPSY TECHNIQUES MARKET OUTLOOK
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Product Offered
8.2.2. By Technique
8.2.3. By Circulating Biomarker
8.2.4. By Application
8.2.5. By End User
8.2.6. By Country
8.3. Asia Pacific: Country Analysis
8.3.1. China Minimally Invasive Biopsy Techniques Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Product Offered
8.3.1.2.2. By Technique
8.3.1.2.3. By Circulating Biomarker
8.3.1.2.4. By Application
8.3.1.2.5. By End User
8.3.2. India Minimally Invasive Biopsy Techniques Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Product Offered
8.3.2.2.2. By Technique
8.3.2.2.3. By Circulating Biomarker
8.3.2.2.4. By Application
8.3.2.2.5. By End User
8.3.3. Japan Minimally Invasive Biopsy Techniques Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Product Offered
8.3.3.2.2. By Technique
8.3.3.2.3. By Circulating Biomarker
8.3.3.2.4. By Application
8.3.3.2.5. By End User
8.3.4. South Korea Minimally Invasive Biopsy Techniques Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Product Offered
8.3.4.2.2. By Technique
8.3.4.2.3. By Circulating Biomarker
8.3.4.2.4. By Application
8.3.4.2.5. By End User
8.3.5. Australia Minimally Invasive Biopsy Techniques Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Product Offered
8.3.5.2.2. By Technique
8.3.5.2.3. By Circulating Biomarker
8.3.5.2.4. By Application
8.3.5.2.5. By End User
9. MIDDLE EAST & AFRICA MINIMALLY INVASIVE BIOPSY TECHNIQUES MARKET OUTLOOK
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Product Offered
9.2.2. By Technique
9.2.3. By Circulating Biomarker
9.2.4. By Application
9.2.5. By End User
9.2.6. By Country
9.3. Middle East & Africa: Country Analysis
9.3.1. Saudi Arabia Minimally Invasive Biopsy Techniques Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Product Offered
9.3.1.2.2. By Technique
9.3.1.2.3. By Circulating Biomarker
9.3.1.2.4. By Application
9.3.1.2.5. By End User
9.3.2. UAE Minimally Invasive Biopsy Techniques Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Product Offered
9.3.2.2.2. By Technique
9.3.2.2.3. By Circulating Biomarker
9.3.2.2.4. By Application
9.3.2.2.5. By End User
9.3.3. South Africa Minimally Invasive Biopsy Techniques Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Product Offered
9.3.3.2.2. By Technique
9.3.3.2.3. By Circulating Biomarker
9.3.3.2.4. By Application
9.3.3.2.5. By End User
10. SOUTH AMERICA MINIMALLY INVASIVE BIOPSY TECHNIQUES MARKET OUTLOOK
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Product Offered
10.2.2. By Technique
10.2.3. By Circulating Biomarker
10.2.4. By Application
10.2.5. By End User
10.2.6. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Minimally Invasive Biopsy Techniques Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Product Offered
10.3.1.2.2. By Technique
10.3.1.2.3. By Circulating Biomarker
10.3.1.2.4. By Application
10.3.1.2.5. By End User
10.3.2. Colombia Minimally Invasive Biopsy Techniques Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Product Offered
10.3.2.2.2. By Technique
10.3.2.2.3. By Circulating Biomarker
10.3.2.2.4. By Application
10.3.2.2.5. By End User
10.3.3. Argentina Minimally Invasive Biopsy Techniques Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Product Offered
10.3.3.2.2. By Technique
10.3.3.2.3. By Circulating Biomarker
10.3.3.2.4. By Application
10.3.3.2.5. By End User
11. MARKET DYNAMICS
11.1. Drivers
11.2. Challenges
12. MARKET TRENDS & DEVELOPMENTS
12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments
13. GLOBAL MINIMALLY INVASIVE BIOPSY TECHNIQUES MARKET: SWOT ANALYSIS
14. PORTER'S FIVE FORCES ANALYSIS
14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products
15. COMPETITIVE LANDSCAPE
15.1. F. Hoffmann-La Roche AG
15.1.1. Business Overview
15.1.2. Products & Services
15.1.3. Recent Developments
15.1.4. Key Personnel
15.1.5. SWOT Analysis
15.2. Thermo Fisher Scientific, Inc.
15.3. PerkinElmer Inc.
15.4. QIAGEN NV
15.5. Guardant Health, Inc.
15.6. Veracyte, Inc.
15.7. Myriad Genetics, Inc.
15.8. Biocept, Inc.
15.9. NeoGenomics Laboratories, Inc.
15.10. Adaptive Biotechnologies Corporation
16. STRATEGIC RECOMMENDATIONS
17. ABOUT US & DISCLAIMER
